Call for Papers now open! We welcome the submission of manuscripts focused on the application of cardiac imaging to the study of health disparities, including investigations of understudied diseases, access to care, and other diverse topics. https://t.co/OuSMEJIOiS #AHAJournals
.@ACCinTouch's 🆕 Expert Consensus Decision Pathway provides practical and timely guidance on the diagnosis and management of cardiac #amyloidosis, with an emphasis on comprehensive multidisciplinary care.
Learn more: https://t.co/1SunbtuQpO
#JACC#CardioOnc#CardioTwitter
@CircImaging@frederickruberg@cshenoy3@AllisonGHaysMD Identification of TTR cardiac amyloidosis in previously diagnosed HCM utilizing cardiac scintigraphy in consecutive patients. 3% of patients >60 yrs had TTR-CM including 8% of previously diagnosed nonobstructive HCM patients. @LaheyCardiology @MartinMaronMD
Happy Holidays! I'm happy to post this opportunity for clinical and research training in the 23-24 AY in #amyloidosis at @The_BMC and @BUMedicine. Please apply by January 13, 2023 if interested and DM/email with questions. @BU_Amyloidosis@BUcards
Huge congratulations to my dear friend and colleague, wonderful mentor, inspirational leader and researcher @DorbalaSharmila on her #AHA2022 Clinical Council #WIC Mentoring Award! Thank you for mentoring so many of us! @RBP0612 @NitiCardio @sarahcud
Our very own Dr. Ruberg, Dr. Siddiqi, Dr. Lau & Dr. Kaku will be presenting at an @Amyloidosisfdn webinar one week from today on October 28! Register to learn more about updates in ATTR Cardiac and Neurological Amyloidosis @frederickruberg@omarsiddiqi https://t.co/EcEJC3mp1n